• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白与神经元细胞死亡。

α-Synuclein and neuronal cell death.

机构信息

Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

出版信息

Mol Neurobiol. 2013 Apr;47(2):466-83. doi: 10.1007/s12035-012-8327-0. Epub 2012 Aug 31.

DOI:10.1007/s12035-012-8327-0
PMID:22936307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3589663/
Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting ~1 % of people over the age of 65. Neuropathological hallmarks of PD are prominent loss of dopaminergic (DA) neurons in the substantia nigra and formation of intraneuronal protein inclusions termed Lewy bodies, composed mainly of α-synuclein (αSyn). Missense mutations in αSyn gene giving rise to production of degradation-resistant mutant proteins or multiplication of wild-type αSyn gene allele can cause rare inherited forms of PD. Therefore, the existence of abnormally high amount of αSyn protein is considered responsible for the DA neuronal death in PD. Normally, αSyn protein localizes to presynaptic terminals of neuronal cells, regulating the neurotransmitter release through the modulation of assembly of soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex. On the other hand, of note, pathological examinations on the recipient patients of fetal nigral transplants provided a prion-like cell-to-cell transmission hypothesis for abnormal αSyn. The extracellular αSyn fibrils can internalize to the cells and enhance intracellular formation of protein inclusions, thereby reducing cell viability. These findings suggest that effective removal of abnormal species of αSyn in the extracellular space as well as intracellular compartments can be of therapeutic relevance. In this review, we will focus on αSyn-triggered neuronal cell death and provide possible disease-modifying therapies targeting abnormally accumulating αSyn.

摘要

帕金森病(PD)是一种进行性神经退行性疾病,影响 65 岁以上人群的 1%左右。PD 的神经病理学标志是黑质中多巴胺能(DA)神经元的明显丧失和称为路易体的细胞内蛋白包涵体的形成,主要由α-突触核蛋白(αSyn)组成。αSyn 基因的错义突变导致产生降解抗性的突变蛋白或野生型 αSyn 基因等位基因的倍增可能导致罕见的遗传性 PD 形式。因此,异常高水平的αSyn 蛋白被认为是 PD 中 DA 神经元死亡的原因。正常情况下,αSyn 蛋白定位于神经元细胞的突触前末端,通过调节可溶性 N-乙基马来酰亚胺敏感因子附着蛋白受体复合物的组装来调节神经递质的释放。另一方面,值得注意的是,对胎儿黑质移植接受者的病理检查提供了一个异常αSyn 的朊病毒样细胞间传播假说。细胞外的αSyn 纤维可以内化到细胞中,并增强细胞内蛋白包涵体的形成,从而降低细胞活力。这些发现表明,有效去除细胞外空间和细胞内隔室中异常的αSyn 物种可能具有治疗相关性。在这篇综述中,我们将重点讨论αSyn 引发的神经元细胞死亡,并提供针对异常积累的αSyn 的可能的疾病修饰治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5e2/3589663/e2423424fb9d/12035_2012_8327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5e2/3589663/692488e176d0/12035_2012_8327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5e2/3589663/e2423424fb9d/12035_2012_8327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5e2/3589663/692488e176d0/12035_2012_8327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5e2/3589663/e2423424fb9d/12035_2012_8327_Fig2_HTML.jpg

相似文献

1
α-Synuclein and neuronal cell death.α-突触核蛋白与神经元细胞死亡。
Mol Neurobiol. 2013 Apr;47(2):466-83. doi: 10.1007/s12035-012-8327-0. Epub 2012 Aug 31.
2
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.α-突触核蛋白和 parkin 在神经元细胞凋亡中的调节作用;对帕金森病发病机制的可能影响。
Apoptosis. 2010 Nov;15(11):1312-21. doi: 10.1007/s10495-010-0486-8.
3
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.14-3-3 蛋白减少致病性 α-突触核蛋白的细胞间转移和传播。
J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9.
4
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.α-突触核蛋白抑制线粒体蛋白酶 ClpP 以触发线粒体氧化损伤和神经毒性。
Acta Neuropathol. 2019 Jun;137(6):939-960. doi: 10.1007/s00401-019-01993-2. Epub 2019 Mar 15.
5
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.泛素羧基末端水解酶L1对帕金森病α-突触核蛋白过表达小鼠模型的影响。
J Neurochem. 2009 Feb;108(4):932-44. doi: 10.1111/j.1471-4159.2008.05827.x. Epub 2009 Jan 7.
6
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.半乳糖凝集素-3 塑造帕金森病中的毒性α-突触核蛋白菌株。
Acta Neuropathol. 2023 Jul;146(1):51-75. doi: 10.1007/s00401-023-02585-x. Epub 2023 May 18.
7
Neuropathology of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的神经病理学。
Neuropathology. 2022 Apr;42(2):93-103. doi: 10.1111/neup.12812. Epub 2022 Mar 31.
8
Accumulation of α-synuclein triggered by presynaptic dysfunction.α-突触核蛋白在突触前功能障碍触发下的积累。
J Neurosci. 2012 Nov 28;32(48):17186-96. doi: 10.1523/JNEUROSCI.2220-12.2012.
9
Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.海藻糖在暴露于α-突触核蛋白预形成纤维时并不能提高神经元存活率。
Redox Biol. 2017 Apr;11:429-437. doi: 10.1016/j.redox.2016.12.032. Epub 2017 Jan 3.
10
Modulation of alpha-synuclein aggregation by dopamine: a review.多巴胺对α-突触核蛋白聚集的调节:综述。
Neurochem Res. 2009 Oct;34(10):1838-46. doi: 10.1007/s11064-009-9986-8. Epub 2009 May 15.

引用本文的文献

1
Advancements in PROTAC-based therapies for neurodegenerative diseases.基于PROTAC的神经退行性疾病治疗方法的进展。
Future Med Chem. 2025 Mar;17(5):591-605. doi: 10.1080/17568919.2025.2463310. Epub 2025 Feb 11.
2
First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy.脊髓性肌萎缩症患者硬膜外脊髓刺激的首例人体研究。
Nat Med. 2025 Apr;31(4):1246-1256. doi: 10.1038/s41591-024-03484-8. Epub 2025 Feb 5.
3
The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies.

本文引用的文献

1
A soluble α-synuclein construct forms a dynamic tetramer.一种可溶性α-突触核蛋白构建体形成动态四聚体。
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17797-802. doi: 10.1073/pnas.1113260108. Epub 2011 Oct 17.
2
Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.外源性α-突触核蛋白纤维诱导路易体病理,导致突触功能障碍和神经元死亡。
Neuron. 2011 Oct 6;72(1):57-71. doi: 10.1016/j.neuron.2011.08.033.
3
E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
单克隆抗体疗法对创伤性脑损伤病理的相关性及影响
Biomedicines. 2024 Nov 26;12(12):2698. doi: 10.3390/biomedicines12122698.
4
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders.揭示植物大麻素的潜力:探索大麻中鲜为人知的成分对神经紊乱的作用。
Biomolecules. 2024 Oct 13;14(10):1296. doi: 10.3390/biom14101296.
5
Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.聚焦肠脑轴:多酚、微生物群及其对帕金森病中α-突触核蛋白的影响。
Nutrients. 2024 Jun 27;16(13):2041. doi: 10.3390/nu16132041.
6
Nuclear alpha-synuclein accelerates cell senescence and neurodegeneration.细胞核内的α-突触核蛋白会加速细胞衰老和神经退行性变。
Immun Ageing. 2024 Jul 12;21(1):47. doi: 10.1186/s12979-024-00429-0.
7
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.帕金森病患者外周血单个核细胞中寡聚化α-突触核蛋白的免疫反应。
J Neurol. 2024 Sep;271(9):5916-5929. doi: 10.1007/s00415-024-12554-3. Epub 2024 Jul 10.
8
Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?阿尔茨海默病和帕金森病的药物研发:我们如今何去何从?
Pharmaceutics. 2024 May 24;16(6):708. doi: 10.3390/pharmaceutics16060708.
9
An Overview of Epigenetic Changes in the Parkinson's Disease Brain.帕金森病大脑中的表观遗传学改变概述。
Int J Mol Sci. 2024 Jun 3;25(11):6168. doi: 10.3390/ijms25116168.
10
Extracellular high molecular weight α-synuclein oligomers induce cell death by disrupting the plasma membrane.细胞外高分子量α-突触核蛋白寡聚体通过破坏质膜诱导细胞死亡。
NPJ Parkinsons Dis. 2023 Sep 28;9(1):139. doi: 10.1038/s41531-023-00583-0.
E46K 人类α-突触核蛋白转基因小鼠出现路易小体样和tau 病理学改变,伴有年龄依赖性、进行性运动障碍。
J Biol Chem. 2011 Oct 7;286(40):35104-18. doi: 10.1074/jbc.M111.247965. Epub 2011 Aug 16.
4
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.α-突触核蛋白在生理条件下以螺旋折叠的四聚体形式存在,能够抵抗聚集。
Nature. 2011 Aug 14;477(7362):107-10. doi: 10.1038/nature10324.
5
Genetically engineered mouse models of Parkinson's disease.帕金森病的基因工程小鼠模型。
Brain Res Bull. 2012 May 1;88(1):13-32. doi: 10.1016/j.brainresbull.2011.07.019. Epub 2011 Aug 3.
6
Prion-like acceleration of a synucleinopathy in a transgenic mouse model.朊病毒样加速在转基因小鼠模型中的突触核蛋白病。
Neurobiol Aging. 2012 Sep;33(9):2225-8. doi: 10.1016/j.neurobiolaging.2011.06.022. Epub 2011 Aug 3.
7
Enhanced autophagy from chronic toxicity of iron and mutant A53T α-synuclein: implications for neuronal cell death in Parkinson disease.慢性铁毒性和突变 A53Tα-突触核蛋白增强的自噬:帕金森病神经元细胞死亡的意义。
J Biol Chem. 2011 Sep 23;286(38):33380-9. doi: 10.1074/jbc.M111.268409. Epub 2011 Jul 27.
8
Fighting neurodegeneration with rapamycin: mechanistic insights.用雷帕霉素对抗神经退行性疾病:机制见解。
Nat Rev Neurosci. 2011 Jul 20;12(8):437-52. doi: 10.1038/nrn3068.
9
Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.Parkin 介导的慢性 MPTP 微泵小鼠帕金森病模型中多巴胺能神经元的保护作用。
J Neuropathol Exp Neurol. 2011 Aug;70(8):686-97. doi: 10.1097/NEN.0b013e3182269ecd.
10
Sumoylation inhibits alpha-synuclein aggregation and toxicity.泛素化抑制 alpha-突触核蛋白聚集和毒性。
J Cell Biol. 2011 Jul 11;194(1):49-60. doi: 10.1083/jcb.201010117.